These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7239409)

  • 1. [The importance of aluminiun in dialyseencephalopathie (author's transl)].
    Ladurner G; Holzer H; Wawschinek O; Pogglitsch H; Petek W
    Fortschr Neurol Psychiatr; 1981 May; 49(5):211-3. PubMed ID: 7239409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
    Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
    Cartier F; Allain P; Gary J; Chatel M; Menault F; Pecker S
    Nouv Presse Med; 1978 Jan; 7(2):97-102. PubMed ID: 652514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
    Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of brain atrophy by computer tomography (author's transl)].
    Meese W; Grumme T
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Sep; 48(9):494-509. PubMed ID: 6903173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of dialysis encephalopathy in the context of rubidium and aluminum levels in the blood and cerebral cortex of patients with concomitant uremic polyneuropathy on long-term dialysis].
    Adamiec R; Uzar J
    Przegl Lek; 1987; 44(3):309-14. PubMed ID: 3615935
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ; Sharf B; Bell P; Meyers AM
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological findings and serum aluminium in dialysis encephalopathy.
    Ladurner G; Wawschinek O; Pogglitsch H; Petek W; Urlesberger H; Holzer H
    Eur Neurol; 1982; 21(5):335-9. PubMed ID: 7117320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of hemodialysis-induced brain disease with intracranial calcinosis].
    Nakanishi T; Tamura T; Miyazaki H; Osawa K; Fukuro Y; Kishima Y; Shoji T; Sasaoka T; Kubota S
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):280-2. PubMed ID: 8492033
    [No Abstract]   [Full Text] [Related]  

  • 15. [A long-term organic brain syndrome and brain stem symptoms in an undiagnosed dialysis-associated encephalopathy].
    Reusche E; Gerke P; Krüger S; Rohwer J; Lindner B; Rob PM
    Dtsch Med Wochenschr; 1999 Feb; 124(7):176-81. PubMed ID: 10093576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids.
    Rovelli E; Luciani L; Pagani C; Albonico C; Colleoni N; D'Amico G
    Clin Nephrol; 1988 Jun; 29(6):294-8. PubMed ID: 3396232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
    Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U
    Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis encephalopathy: precipitating factors and improvement in prognosis.
    Platts MM; Anastassiades E
    Clin Nephrol; 1981 May; 15(5):223-8. PubMed ID: 7249421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.